| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 90.807 | 257.985 | 450.284 | 405.466 | 387.006 | 328.325 | 322.207 |
| Total Income - EUR | 0 | 0 | 0 | 90.807 | 257.985 | 450.293 | 405.491 | 387.026 | 328.325 | 322.247 |
| Total Expenses - EUR | 0 | 0 | 209 | 88.863 | 213.326 | 325.262 | 314.398 | 353.239 | 269.740 | 307.362 |
| Gross Profit/Loss - EUR | 0 | 0 | -209 | 1.944 | 44.659 | 125.031 | 91.093 | 33.787 | 58.585 | 14.885 |
| Net Profit/Loss - EUR | 0 | 0 | -209 | 1.014 | 42.079 | 120.540 | 87.525 | 30.110 | 55.868 | 6.417 |
| Employees | 0 | 0 | 0 | 4 | 5 | 6 | 8 | 7 | 6 | 6 |
Check the financial reports for the company - Hiperclinica Tulkarem Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 32.794 | 32.192 | 31.569 | 37.770 | 192.831 | 193.129 | 192.798 | 189.440 |
| Current Assets | 45 | 45 | 11.280 | 12.614 | 20.218 | 49.842 | 90.064 | 36.671 | 57.065 | 25.025 |
| Inventories | 0 | 0 | 10.623 | 11.411 | 4.520 | 7.199 | 16.219 | 29.228 | 10.060 | 11.480 |
| Receivables | 0 | 0 | 84 | 667 | 6.813 | 17.025 | 69.416 | 5.835 | 42.470 | 7.504 |
| Cash | 45 | 45 | 573 | 536 | 8.885 | 25.618 | 4.429 | 1.608 | 4.534 | 6.040 |
| Shareholders Funds | 45 | 45 | 229 | 852 | 42.915 | 162.642 | 239.467 | 162.676 | 218.051 | 195.451 |
| Social Capital | 45 | 45 | 438 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 0 | 43.845 | 43.954 | 175.811 | 86.064 | 43.428 | 67.123 | 31.812 | 21.967 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Hiperclinica Tulkarem Srl